Efficacy of neoadjuvant systemic carboplatin therapy in triple-negative breast cancer

被引：0
|
作者：
Thomssen, Christoph
Schuler, Kathleen
Bauer, Marcus
Reinhardt, Kristin
Strauss, Hans-Gerorg
Vetter, Martina
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P2-12-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-12-05
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
    Silver, Daniel P.
    Richardson, Andrea L.
    Eklund, Aron C.
    Wang, Zhigang C.
    Szallasi, Zoltan
    Li, Qiyuan
    Juul, Nicolai
    Leong, Chee-Onn
    Calogrias, Diana
    Buraimoh, Ayodele
    Fatima, Aquila
    Gelman, Rebecca S.
    Ryan, Paula D.
    Tung, Nadine M.
    De Nicolo, Arcangela
    Ganesan, Shridar
    Miron, Alexander
    Colin, Christian
    Sgroi, Dennis C.
    Ellisen, Leif W.
    Winer, Eric P.
    Garber, Judy E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : 1145 - 1153
  • [2] Triple-negative Breast Carcinoma: Carboplatin and Veliparib in the Neoadjuvant
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2018, 78 (07)
  • [3] Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients
    Candelaria, Rosalind P.
    Adrada, Beatriz E.
    Hess, Kenneth
    Santiago, Lumarie
    Lane, Deanna L.
    Thompson, Alastair M.
    Moulder, Stacy L.
    Huang, Monica L.
    Arribas, Elsa M.
    Rauch, Gaiane M.
    Leung, Jessica W. T.
    Symmans, W. Fraser
    Valero, Vicente
    Ravenberg, Elizabeth E.
    White, Jason B.
    Yang, Wei Tse
    EUROPEAN JOURNAL OF RADIOLOGY, 2020, 130
  • [4] Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts
    Sharma, Priyanka
    Lopez-Tarruella, Sara
    Angel Garcia-Saenz, Jose
    Ward, Claire
    Connor, Carol S.
    Gomez, Henry L.
    Prat, Aleix
    Moreno, Fernando
    Jerez-Gilarranz, Yolanda
    Barnadas, Augusti
    Picornell, Antoni C.
    del Monte-Millan, Maria
    Gonzalez-Rivera, Milagros
    Massarrah, Tatiana
    Pelaez-Lorenzo, Beatriz
    Isabel Palomero, Maria
    Gonzalez del Val, Ricardo
    Cortes, Javier
    Fuentes Rivera, Hugo
    Bretel Morales, Denisse
    Marquez-Rodas, Ivan
    Perou, Charles M.
    Wagner, Jamie L.
    Mammen, Joshua M. V.
    McGinness, Marilee K.
    Klemp, Jennifer R.
    Amin, Amanda L.
    Fabian, Carol J.
    Heldstab, Jaimie
    Godwin, Andrew K.
    Jensen, Roy A.
    Kimler, Bruce F.
    Khan, Qamar J.
    Martin, Miguel
    CLINICAL CANCER RESEARCH, 2017, 23 (03) : 649 - 657
  • [5] Progress in systemic therapy for triple-negative breast cancer
    Hongnan Mo
    Binghe Xu
    Frontiers of Medicine, 2021, 15 (01) : 1 - 10
  • [6] Progress in systemic therapy for triple-negative breast cancer
    Mo, Hongnan
    Xu, Binghe
    FRONTIERS OF MEDICINE, 2021, 15 (01) : 1 - 10
  • [7] Progress in systemic therapy for triple-negative breast cancer
    Hongnan Mo
    Binghe Xu
    Frontiers of Medicine, 2021, 15 : 1 - 10
  • [8] Effect of primary systemic carboplatin therapy in triple-negative breast cancer according to the Vanderbilt subtype
    Vetter, M.
    Beck, H.
    Schwarzer, F.
    Stueckrath, K.
    Porsch, M.
    Wickenhauser, C.
    Strauss, H. -G.
    Thomssen, C.
    BREAST, 2017, 32 : S82 - S83
  • [9] Future Developments in Neoadjuvant Therapy for Triple-Negative Breast Cancer
    Moore-Smith, Lakisha
    Forero-Torres, Andres
    Stringer-Reasor, Erica
    SURGICAL CLINICS OF NORTH AMERICA, 2018, 98 (04) : 773 - +
  • [10] Neoadjuvant Therapy in early triple-negative Breast Cancer strengthened
    Klein, Friederike
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2025, 150 (07)
12345